Evidence map›Paper›PMID 26046315›Full record

ArticleScientific reports2015

Genetic variants in 3'-UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Koreans.

Young Joo Jeon, Jong Woo Kim, Hye Mi Park, Jung O Kim, Hyo Geun Jang, Jisu Oh, Seong Gyu Hwang, Sung Won Kwon, Doyeun Oh, Nam Keun Kim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. The Roles ofNutrients · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Clinical and experimental reproductive medicine · 2017
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Young Joo JeonInstitute for Clinical Research, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Jong Woo KimDepartment of Surgery, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Hye Mi ParkInstitute for Clinical Research, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Jung O KimInstitute for Clinical Research, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Hyo Geun JangInstitute for Clinical Research, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Jisu OhDepartment of Internal Medicine, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Seong Gyu HwangDepartment of Internal Medicine, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Sung Won KwonDepartment of Surgery, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Doyeun OhDepartment of Internal Medicine, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
Nam Keun KimInstitute for Clinical Research, School of Medicine, CHA University, 351 Yatap-dong, Bundang-gu, Seongnam 463-712, South Korea.
CHA University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) play important roles in tumor development, progression, and metastasis. Moreover, recent studies have reported that a number of 3'-UTR polymorphisms potentially bind to specific microRNAs in a variety of cancers. The aim of this study was to investigate the association of four MTHFR polymorphisms, 2572C>A [rs4846049], 4869C>G [rs1537514], 5488C>T [rs3737967], and 6685T>C [rs4846048] with colorectal cancer (CRC) in Koreans. A total of 850 participants (450 CRC patients and 400 controls) were enrolled in the study. The genotyping of MTHFR 3'-UTR polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism analysis or TaqMan allelic discrimination assay. We found that MTHFR 2572C>A, 4869C>G, and 5488C>T genotypes were substantially associated with CRC susceptibility. Of the potentially susceptible polymorphisms, MTHFR 2572C>A was associated with increased homocysteine and decreased folate levels in the plasma based on MTHFR 677CC. Our study provides the evidences for 3'-UTR variants in MTHFR gene as potential biomarkers for use in CRC prevention.

Indexed as

3' Untranslated RegionsAdenocarcinomaAgedColorectal NeoplasmsFemaleFolic AcidGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHomocysteineHumansMaleMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedPolymorphism, Single NucleotideRepublic of Korea3' Untranslated RegionsFolic AcidHomocysteineMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, human

Identifiers

PMID26046315
PMCPMC4457011
OpenAlexW571844663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.